Doctor profile · Federal record
Dr. SARO KASPARIAN, M.D.
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Student in an Organized Health Care Education/Training Program · GLENDALE, CA
- NPI 1104350917
- Accepts Medicare
- MIPS 96.9 / 100 · 2023
- 9 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1505 WILSON TER STE 200
GLENDALE, CA 912064073
(818) 409-0105
fax (818) 409-0151 - Additional location
-
222 W Eulalia St Ste 100C
Glendale, CA 912042850
(818) 553-8160
fax (818) 553-8152 - Mailing address
-
541 W COLORADO ST STE 205
GLENDALE, CA 912043640
Credentials & registration
- NPI registered
- April 2017 — 9 yrs on file
- Profile last updated
- May 15, 2023
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A166690
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1104350917. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,597
Distinct HCPCS
10
Medicare allowed
$230,166
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,004 | 36 | $44 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,516 | 64 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 1,262 | 11 | $24 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 350 | 230 | $139 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 239 | 176 | $8 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 164 | 14 | $1 | |
96127 |
Assessment of emotional or behavioral problems | 123 | 123 | $5 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 108 | 62 | $33 | |
J1200 |
Injection, diphenhydramine hcl, up to 50 mg | 93 | 59 | $1 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 86 | 21 | $125 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 2,144. This provider delivers 3.1× the peer median.Open Payments
Industry payments received
All-time total
$6,330
Transactions
173
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $663.68 | |
| Celgene Corporation | 23 | $381.72 | |
| Astellas Pharma US Inc | 16 | $369.89 | |
| Incyte Corporation | 10 | $359.40 | |
| Janssen Biotech, Inc. | 11 | $304.16 | |
| PFIZER INC. | 16 | $295.46 | |
| Merck Sharp & Dohme LLC | 10 | $292.23 | |
| E.R. Squibb & Sons, L.L.C. | 13 | $252.75 | |
| Lilly USA, LLC | 9 | $251.71 | |
| Eisai Inc. | 10 | $248.86 | |
| Novartis Pharmaceuticals Corporation | 13 | $224.47 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $201.49 | |
| GENZYME CORPORATION | 5 | $157.27 | |
| ABBVIE INC. | 6 | $154.93 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $145.42 |